Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
cinzia.milito@uniroma1.it
Cinzia Milito
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA MOLECOLARE
E-mail:
cinzia.milito@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study
JOURNAL OF CLINICAL IMMUNOLOGY
2024
Clinical impact of transient lymphopenia
CLINICAL AND EXPERIMENTAL MEDICINE
2024
Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency
FRONTIERS IN IMMUNOLOGY
2024
Non-Infectious Pneumonitis and Acute Respiratory Distress Syndrome in a Patient on Ustekinumab Treatment: Case Report and Literature Review
LIFE
2024
Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review
BIOMEDICINES
2024
Struggling with COVID-19 in adult inborn errors of immunity patients: a case series of combination therapy and multiple lines of therapy for selected patients
LIFE
2023
Common and uncommon CT findings in CVID-related GL-ILD: correlations with clinical parameters, therapeutic decisions and potential implications in the differential diagnosis
JOURNAL OF CLINICAL IMMUNOLOGY
2023
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters
FRONTIERS IN IMMUNOLOGY
2023
Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review
FRONTIERS IN IMMUNOLOGY
2023
Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis
CANCERS
2023
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022
FRONTIERS IN IMMUNOLOGY
2023
SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience
FRONTIERS IN IMMUNOLOGY
2023
SARS-CoV-2 vaccination in primary antibody deficiencies: an overview on efficacy, immunogenicity, durability of immune response and safety
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY
2023
Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job's syndrome
ALLERGY, ASTHMA, AND CLINICAL IMMUNOLOGY
2023
Defective peripheral B cell selection in common variable immune deficiency patients with autoimmune manifestations
CELL REPORTS
2023
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022
FRONTIERS IN IMMUNOLOGY
2023
Reply to Özdemir, Ö. Allergic Disease with Selective IgA Deficiency. Comment on "Cinicola et al. The Allergic Phenotype of Children and Adolescents with Selective IgA Deficiency: A Longitudinal Monocentric Study. J. Clin. Med. 2022, 11, 5705"
JOURNAL OF CLINICAL MEDICINE
2023
A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes
FRONTIERS IN IMMUNOLOGY
2023
Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study
JOURNAL OF CLINICAL IMMUNOLOGY
2023
Subcutaneous Gammanorm® by pump or rapid push infusion: Impact of the device on quality of life in adult patients with primary immunodeficiencies
CLINICAL IMMUNOLOGY
2022
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
Studio longitudinale sulla valutazione della Qualità Di Vita Relata alla Salute (Health Related Quality of Life) nei pazienti con Immuno Deficienze Primitive Anticorpali in trattamento con terapia sostitutiva con immunoglobuline umane polivalenti
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma